GGrantIndex
Sort

51,593 grants matching hepatitis

Molecular Mechanisms of Insulin Resistance Associated Loci

$546,913
Thomas None Quertermous · Stanford University · R01 · FY2017 · DK

Metabolic Syndrome in PCOS: Precursors and Interventions

$546,909
Andrea Dunaif · Northwestern University At Chicago · R01 · FY2008 · DK

Regulation of Drug Metabolizing Enzyme Ontogeny

$546,881
Ronald N Hines · Medical College Of Wisconsin · R01 · FY2010 · GM

Regulation of Sex Differences in Liver Metabolism

$546,761
David J Waxman · Boston University (Charles River Campus) · R01 · FY2014 · DK

Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses

$546,751
Genevieve Giny Fouda Amou Ou · Duke University · P01 · FY2020 · AI

CEACAM1 Alternative Splicing in Liver Ischemia-Reperfusion Injury

$546,710
Jerzy W. Kupiec-Weglinski · University Of California Los Angeles · P01 · FY2025 · AI

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2016 · AI

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2014 · AI

Identification and characterization of cellular factors involved in HCV entry

$546,673
Charles M. Rice · Rockefeller University · R01 · FY2015 · AI

Epidemiology of Oncogenic Viruses

$546,673
Thomas R O'Brien · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA

Hyperhomocysteinemia and HDL Metabolism

$546,657
Hong Wang · Temple Univ Of The Commonwealth · R01 · FY2013 · HL

A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis

$546,636
Hashem B El-Serag · Baylor College Of Medicine · R01 · FY2018 · CA

HCV-specific T cell response

$546,488
Christopher M. Walker · Research Inst Nationwide Children'S Hosp · R37 · FY2009 · AI

Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance

$546,459
Qing Miao · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2025 · DK

Risk Reduction for Young African American IDUs

$546,392
Tulane University Of Louisiana · R01 · FY2004 · DA

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B

$546,382
Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Genomics and pharmacodynamics of statin-related rhabdomyolysis

$546,350
Bruce M Psaty · University Of Washington · R01 · FY2012 · HL

Inflammation, Stress, and Social Behavior: Using Ecological Assessments and Model

$546,327
Charles L Raison · University Of Arizona · R01 · FY2011 · AT

Control of Lipogenesis and Hepatic Steatosis by Caspase-2

$546,309
Michael Karin · University Of California, San Diego · R01 · FY2023 · DK

ANGPTL3 DEFICIENCY AND ATHEROSCLEROSIS IN HUMANS

$546,270
Nathan Oliver Stitziel · Washington University · R01 · FY2020 · HL

Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network

$546,250
Jeffrey Easler · Indiana University Indianapolis · U01 · FY2025 · DK

Functional Genomics and HCV-Associated Liver Disease

$546,235
Michael G Katze · University Of Washington · P30 · FY2012 · DA

Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation

$546,219
Peter Philip Reese · University Of Pennsylvania · R01 · FY2022 · DK

Novel molecular imaging approaches to monitor gene and cell-based therapies

$546,171
Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2013 · CA

Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I

$546,164
Raymond Yu Jeang Wang · Children'S Hospital Of Orange County · R01 · FY2025 · HD